These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8563186)

  • 1. Ethanol potentiates valproic acid-induced neural tube defects (NTDs) in mice due to toxicokinetic interactions.
    Elmazar MM; Nau H
    Reprod Toxicol; 1995; 9(5):427-33. PubMed ID: 8563186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim potentiates valproic acid-induced neural tube defects (NTDs) in mice.
    Elmazar MM; Nau H
    Reprod Toxicol; 1993; 7(3):249-54. PubMed ID: 8318756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice.
    Elmazar MM; Nau H
    Teratog Carcinog Mutagen; 1992; 12(5):203-10. PubMed ID: 1363493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of dam and conceptus to differences in sensitivity to valproic acid among C57 black and SWV mice.
    Beck SL
    Reprod Toxicol; 1999; 13(5):353-60. PubMed ID: 10560583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen.
    Nau H
    Fundam Appl Toxicol; 1986 May; 6(4):662-8. PubMed ID: 3086173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse.
    Nau H
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):243-50. PubMed ID: 3927520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
    Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
    Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
    Hishida R; Nau H
    Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
    Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
    Radatz M; Ehlers K; Yagen B; Bialer M; Nau H
    Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
    Padmanabhan R; Shafiullah MM
    Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
    Elmazar MM; Thiel R; Nau H
    Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping a chromosomal locus for valproic acid-induced exencephaly in mice.
    Lundberg YW; Cabrera RM; Greer KA; Zhao J; Garg R; Finnell RH
    Mamm Genome; 2004 May; 15(5):361-9. PubMed ID: 15170225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses [corrected].
    Padmanabhan R; Ahmed I
    Reprod Toxicol; 1996; 10(5):345-63. PubMed ID: 8888407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
    Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.